Clinical Trial Update: Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible Mutation

View source ↗

Summary

A completed clinical trial evaluating quality of life and nasal-sinus symptoms in children aged 6 to 11 with cystic fibrosis treated with CFTR modulators.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• CFTR modulators

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cystic Fibrosis | Status: COMPLETED